1. Inicio
  2. Acciones
  3. Reino Unido
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. Noticias
  7. Otros idiomas
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Reporte
Diferido London Stock Exchange  -  17:38 06/07/2022
10970.00 GBX   +1.57%
05/07Las bolsas europeas se ven afectadas por el temor a la recesión; el euro cae a su mínimo en 20 años
MT
05/07ASTRAZENECA : Deutsche Bank mantiene su recomendación de compra
MD
05/07AstraZeneca adquirirá el fabricante de medicamentos contra el cáncer TeneoTwo
MT
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sectorEstrategias MarketScreener
Noticias en otros idiomas sobre ASTRAZENECA PLC
06/07China allows AstraZeneca's COVID preventive drug in southern city
06/07Weak sterling boosts FTSE 100 amid political, growth worries
06/07UK stocks rebound as investors weigh political uncertainty
06/07Astrazeneca inks $1.2bn deal with US biotech firm
05/07European Bourses Hammered by Recession Fears; Euro Falls to 20-Year Low
05/07GLOBAL MARKETS LIVE : J Sainsbury, Foxconn, JPMorgan, Comcast, Tesla...
05/07AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening ha..
05/07ASTRAZENECA : to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening hae..
05/07MARKETSCREENER'S WORLD PRESS REVIEW : July 5, 2022
05/07ASTRAZENECA : rachat de la biotech TeneoTwo
05/07AstraZeneca to Acquire Cancer Drug Maker TeneoTwo
05/07PETER THIEL : Stock Futures Head Lower as Recession Fears Loom Large
05/07ASTRAZENECA ACHÈTE, SAS EN FAILLITE, : Planète Bourse du mardi 5 juillet
05/07AstraZeneca s'offre l'américain TeneoTwo, pour un montant maximal de 1,27 Md$
05/07ASTRAZENECA : acquisition de TeneoTwo
05/07AstraZeneca Moves to Boost Blood Cancer Pipeline Via $1.3 Billion TeneoTwo Acquisition
05/07AstraZeneca to Buy TeneoTwo in Up to $1.27 Billion Deal
05/07Le retour du duty free ?
05/07EN DIRECT DES MARCHES : Renault, Valeo, Elis, Valora, Sainsbury, Uniper, SAS, AstraZeneca,..
05/07Astrazeneca stärkt mit Teneotwo-Übernahme Hämatologie-Pipeline
05/07AstraZeneca to buy oncology firm TeneoTwo for up to $1.27 billion
05/07AstraZeneca To Buy TeneoTwo in Up tp $1.27 Billion Deal
05/07AstraZeneca to Buy TeneoTwo for Up to $1.27 Billion
05/07AstraZeneca PLC entered into an agreement to acquire TeneoTwo, Inc. from TBio, LLC and ..
01/07SECTOR UPDATE : Health Care Stocks Rebound Late
01/07SECTOR UPDATE : Health Care Stocks Struggling for Direction
01/07AstraZeneca Meets Primary Endpoints in Late-Stage Liver, Biliary Tract Cancers Trials
01/07AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® (durvalumab) Combination..
01/07AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® Combinations in Patients..
01/07AstraZeneca Enters New 3-Year Agreement with Oxford Biomedica
01/07New chronic kidney disease (CKD) study indicates that CKD is present in one out of ten ..
01/07Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN..
01/07Pharmaceutical companies still have the upper hand
01/07Oxford BioMedica Extends Agreement With AstraZeneca for Covid-19 Vaccine Facility
01/07Oxford Biomedica signs new deal to make AstraZeneca COVID shot
01/07Oxford Biomedica, AstraZeneca Unit Ink Three-year Deal To Manufacture COVID-19 Vaccines
01/07Oxford Biomedica signs new deal to make AstraZeneca COVID shot
30/06COVID SCIENCE-Pausing methotrexate improves booster response; first-trimester of pregna..
30/06IMFINZI® (durvalumab) Plus Chemotherapy Significantly Improved Pathologic Complete Resp..
30/06AstraZeneca Says Phase 3 Trial Interim Data Show Imfinzi Plus Chemotherapy Improves Pat..
30/06ASTRAZENECA : Imfinzi plus chemotherapy significantly improved pathologic complete respons..
30/06Astrazeneca's Imfinzi Plus Chemotherapy Significantly Improves Pathologic Complete Resp..
30/06ASTRAZENECA : Imfinzi prometteur dans le cancer du poumon
30/06S.Korea authorises AstraZeneca COVID therapy Evusheld for vulnerable people
30/06AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial
30/06AstraZeneca's Late-stage Lung Cancer Drug Trial Shows Improved Pathologic Complete Resp..
30/06AstraZeneca Announces Positive High-Level Results from A Planned Interim Analysis of th..
30/06AstraZeneca Says Imfinzi Improved Pathologic Complete Response in Lung Cancer
29/06European ADRs Move Slightly Higher in Wednesday Trading
29/06FTSE 100 Closes Down 0.2% as Uncertainty Persists
29/06FTSE 100 retreats from two-week high on slowdown worries
29/06Taiwan to receive first doses of Novavax COVID vaccine this week
29/06SK Bioscience Shares Advance on Covid-19 Vaccine Approval
28/06AstraZeneca and Merck - LYNPARZA (olaparib) Receives Positive Opinion From EU CHMP as A..
28/06Amref and AstraZeneca launch mobile clinics to support last mile COVID-19 vaccination e..
28/06Amref and AstraZeneca launch mobile clinics to support last mile COVID-19 vaccination e..
27/06ASTRAZENECA : l'Enhertu recommandé par le CMUH
27/06European Union Recommends Approval for AstraZeneca and Daiichi Sankyo's Enhertu
27/06Merck, AstraZeneca's Lynparza Obtains EMA's Committee Recommendation as Adjuvant Treatm..
27/06Enhertu recommended for approval in the EU by CHMP for patients with HER2-positive meta..
27/06AstraZeneca Pharma India Sets Record Date for Fiscal 2022 Final Dividend
27/06SOUTHWEST ÉCONOMISE, RWE MENACE, ZAL : Planète Bourse du lundi 27 juin
27/06AstraZeneca Partner Daiichi Sankyo Says EMA's Committee Backs Approval of Trastuzumab D..
27/06ASTRAZENECA : avis favorable du CHMP pour Enhertu
27/06CHMP empfiehlt Astrazeneca-Brustkrebsmittel Lynparza zur EU-Zulassung
27/06AstraZeneca's Lynparza, Enhertu Win EU Panel's Backing for Approval in Breast Cancer
27/06AstraZeneca PLC Announces Lynparzar Ecommended for Approval in the EU by CHMP as Adjuva..
27/06Trastuzumab Deruxtecan Recommends for Approval in the EU by CHMP for Patients with HER2..
27/06AstraZeneca-Daiichi Sankyo Enhertu Breast Cancer Drug Is Recommended for EU Approval
27/06AstraZeneca Lynparza Breast Cancer Treatment Is Recommended for EU Approval
26/06Neue Daten zu Omikron-Impfstoffen - Unmut über Zulassungspraxis
24/06AstraZeneca-Merck & Co's Lynparza Receives EU Panel's Positive Opinion for New Indicati..
24/06ASTRAZENECA : un nouvel avis positif du CHMP pour le Lynparza
24/06Sanofi, GSK variant-specific COVID shot found effective against Omicron
23/06COVID/VALNEVA : un comité de l'EMA recommande l'autorisation de son vaccin
1  2  3  4  5  6  7  8  9  10Siguiente
Próximo evento sobre ASTRAZENECA PLC